Navigation Links
Timing Of Women's Labor May Determine Effectiveness Of Pain Medication

It has now been found out that women who had day labor got longer pain relief than women with night labor with the same amount of labor pain medicine. This could be due to the impact of natural daily body rhythms // that may influence the effectiveness of spinal-epidural pain medication for women in labor.

Therefore the time of administration of the medication is regarded to be an important factor in determining its effectiveness. In the future, doctors may consider time of day, as well as patient's weight and other factors, when determining the best dose or method of drug delivery. The study's goal was to determine if the body's natural internal rhythms can affect the effectiveness of pain medication for laboring women. The study, involved 77 women who were in labor with their first babies and requested spinal-epidural pain medication.

The biological rhythms studied include the circadian rhythm, the 24-hour body clock, and the ultradian rhythm, shorter-than-24-hour-cycles, which determine sleeping and eating patterns and can also affect blood pressure, heart rate and body temperature. Some rhythms are controlled by sunlight and others are controlled internally.

The researchers found that women who labored between noon and 6 p.m. got an average of 27 percent longer pain relief from a single dose of the spinal-epidural medication fentanyl than women whose labor was between 8 p.m. and 2 a.m. This is one of the first studies to examine whether there are chronobiological variations in the effectiveness of a drug for labor pain relief.

Knowing more about how time of administration influences the drug's effects could have significant practical implications for how it is prescribed and delivered. For example, the dose could be tailored to the time of day or a smart, programmable, time-released version of the drug could be developed to optimize desired drug effects and minimize undesired side effects both for women in labor and pati ents with other pain syndromes.

Furthermore, the right treatment given at the wrong time can be ineffective or create a crisis of escalating toxicity. Conversely, even a weak treatment, if given at the right moment, could prove surprisingly effective.


'"/>




Related medicine news :

1. Optimum Timing for HIV/AIDS Prognosis
2. Drink till you drop dead in English Pubs- Restriction on Timings Lifted
3. Minimally Invasive Lung Cancer Surgery Minimize the Treatment Timings
4. Timing of Food Consumption Activates Genes in Specific Brain Area
5. Study on Timing of Spinal Surgery
6. Breast Cancer Risk Influenced by the Timing of Weight Gain
7. Timing of First Intercourse is Vital
8. Timing – Crucial for Asthma Drugs to Wor
9. Unsatisfactory Grade On Womens Health Issues
10. Womens strong sense of smell
11. Womens stroke indications vary from mens
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a ... B-595 and B-7569 vinyl label materials received certification for the ... are tested to remain intact and legible, for use on chemical drums shipped by ...
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... ... April 21, 2017 , ... Westside Dental Associates ... dental care since 1985. After thirty-two years, Dr. Latner has become one of the ... my numerous clients over the years with all their dental needs,” said Dr. Latner, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
Breaking Medicine Technology: